178 related articles for article (PubMed ID: 26129745)
21. Predicting chest wall pain from lung stereotactic body radiotherapy for different fractionation schemes.
Woody NM; Videtic GM; Stephans KL; Djemil T; Kim Y; Xia P
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):427-34. PubMed ID: 22197087
[TBL] [Abstract][Full Text] [Related]
22. Predictors of radiotherapy induced bone injury (RIBI) after stereotactic lung radiotherapy.
Taremi M; Hope A; Lindsay P; Dahele M; Fung S; Purdie TG; Jaffray D; Dawson L; Bezjak A
Radiat Oncol; 2012 Sep; 7():159. PubMed ID: 22985910
[TBL] [Abstract][Full Text] [Related]
23. Late chest wall toxicity after MammoSite breast brachytherapy.
Brashears JH; Dragun AE; Jenrette JM
Brachytherapy; 2009; 8(1):19-25. PubMed ID: 18955019
[TBL] [Abstract][Full Text] [Related]
24. Predictors and management of chest wall toxicity after lung stereotactic body radiotherapy.
Shaikh T; Turaka A
Cancer Treat Rev; 2014 Dec; 40(10):1215-20. PubMed ID: 25261888
[TBL] [Abstract][Full Text] [Related]
25. Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma.
Kanemoto A; Mizumoto M; Okumura T; Takahashi H; Hashimoto T; Oshiro Y; Fukumitsu N; Moritake T; Tsuboi K; Sakae T; Sakurai H
Acta Oncol; 2013 Apr; 52(3):538-44. PubMed ID: 22950386
[TBL] [Abstract][Full Text] [Related]
26. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy: risk factors and dose-volume relationship.
Asai K; Shioyama Y; Nakamura K; Sasaki T; Ohga S; Nonoshita T; Yoshitake T; Ohnishi K; Terashima K; Matsumoto K; Hirata H; Honda H
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):768-73. PubMed ID: 22445398
[TBL] [Abstract][Full Text] [Related]
27. Dose-effect analysis of radiation induced rib fractures after thoracic SBRT.
Stam B; van der Bijl E; Peulen H; Rossi MMG; Belderbos JSA; Sonke JJ
Radiother Oncol; 2017 May; 123(2):176-181. PubMed ID: 28110960
[TBL] [Abstract][Full Text] [Related]
28. Chest wall pain after single-fraction thoracic stereotactic ablative Radiotherapy: Dosimetric analysis from the iSABR trial.
Lau B; Wu YF; Cui S; Fu J; Jackson S; Pham D; Dubrowski P; Eswarappa S; Skinner L; Shirato H; Taguchi H; Gensheimer MF; Gee H; Chin AL; Diehn M; Loo BW; Moiseenko V; Vitzthum LK
Radiother Oncol; 2024 Jul; 196():110317. PubMed ID: 38679202
[TBL] [Abstract][Full Text] [Related]
29. Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer.
Mutter RW; Liu F; Abreu A; Yorke E; Jackson A; Rosenzweig KE
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1783-90. PubMed ID: 21868173
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of single fraction stereotactic ablative radiotherapy for lung metastases.
Filippi AR; Badellino S; Guarneri A; Levis M; Botticella A; Mantovani C; Ragona R; Racca P; Buffoni L; Novello S; Ricardi U
Technol Cancer Res Treat; 2014 Feb; 13(1):37-45. PubMed ID: 23819496
[TBL] [Abstract][Full Text] [Related]
31. Incidence, risk factors, and dose-volume relationship of radiation-induced rib fracture after carbon ion radiotherapy for lung cancer.
Abe T; Shirai K; Saitoh J; Ebara T; Shimada H; Tashiro M; Okano N; Ohno T; Nakano T
Acta Oncol; 2016; 55(2):163-6. PubMed ID: 26399488
[TBL] [Abstract][Full Text] [Related]
32. Clinical Outcome of Stereotactic Ablative Body Radiotherapy for Lung Metastatic Lesions in Non-small Cell Lung Cancer Oligometastatic Patients.
De Rose F; Cozzi L; Navarria P; Ascolese AM; Clerici E; Infante M; Alloisio M; Testori A; Toschi L; Finocchiaro G; Santoro A; Scorsetti M
Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):13-20. PubMed ID: 26385822
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
Lagerwaard FJ; Verstegen NE; Haasbeek CJ; Slotman BJ; Paul MA; Smit EF; Senan S
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):348-53. PubMed ID: 22104360
[TBL] [Abstract][Full Text] [Related]
34. Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors.
Chaudhuri AA; Tang C; Binkley MS; Jin M; Wynne JF; von Eyben R; Hara WY; Trakul N; Loo BW; Diehn M
Lung Cancer; 2015 Jul; 89(1):50-6. PubMed ID: 25997421
[TBL] [Abstract][Full Text] [Related]
35. Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: exploration of clinical indications.
Li Q; Swanick CW; Allen PK; Gomez DR; Welsh JW; Liao Z; Balter PA; Chang JY
Radiother Oncol; 2014 Aug; 112(2):256-61. PubMed ID: 25108807
[TBL] [Abstract][Full Text] [Related]
36. Factors associated with chest wall toxicity after accelerated partial breast irradiation using high-dose-rate brachytherapy.
Brown S; Vicini F; Vanapalli JR; Whitaker TJ; Pope DK; Lyden M; Bruggeman L; Haile KL; McLaughlin MP
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):801-5. PubMed ID: 22245195
[TBL] [Abstract][Full Text] [Related]
37. Lung volume reduction after stereotactic ablative radiation therapy of lung tumors: potential application to emphysema.
Binkley MS; Shrager JB; Leung AN; Popat R; Trakul N; Atwood TF; Chaudhuri A; Maxim PG; Diehn M; Loo BW
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):216-23. PubMed ID: 25015205
[TBL] [Abstract][Full Text] [Related]
38. A cortical thickness and radiation dose mapping approach identifies early thinning of ribs after stereotactic body radiation therapy.
Okoukoni C; Lynch SK; McTyre ER; Randolph DM; Weaver AA; Blackstock AW; Lally BE; Munley MT; Willey JS
Radiother Oncol; 2016 Jun; 119(3):449-53. PubMed ID: 27072937
[TBL] [Abstract][Full Text] [Related]
39. Predictors and characteristics of Rib fracture following SBRT for lung tumors.
Carducci MP; Sundaram B; Greenberger BA; Werner-Wasik M; Kane GC
BMC Cancer; 2023 Apr; 23(1):337. PubMed ID: 37046249
[TBL] [Abstract][Full Text] [Related]
40. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
